Neuroimaging of neurodegenerative disease and healthy aging Gemma Salvadó

Genius P, Calle ML, Rodriguez-Fernandez B, Minguillón C, Cacciaglia R, Garrido D, Esteller M, Navarro A, Gispert JD, Vilor N^*, Alzheimer's Disease Neuroimaging Initiative; ALFA study. Compositional brain scores capture Alzheimer's disease-specific structural brain patterns along the disease continuum. Alzheimers Dement 2025; 21(2): e14490.
Cacciaglia R, Falcón C, Sánchez-Benavides G, Brugulat-Serrat A, Milà M, Suarez-Calvet M, Molinuevo JL, Fauria K, Minguillón C, Kollmorgen G, Quijano-Rubio C, Blennow K, Zetterberg H, Lorenzini L, Wink AM, Ingala S, Barkhof F, Ritchie CW, Gispert JD^*, ALFA study. Soluble Aβ pathology predicts neurodegeneration and cognitive decline independently on p-tau in the earliest Alzheimer's continuum: Evidence across two independent cohorts. Alzheimers Dement 2025; 21(2): e14415.
Cacciaglia R^*, Shekari M, SALVADÓ G, Milà M, Falcón C, Sánchez-Benavides G, Minguillón C, Fauria K, Grau-Rivera O, Molinuevo JL, Blennow K, Zetterberg H, Quevenco FC, Suarez-Calvet M, Gispert JD, ALFA Study. The CSF p-tau/β-amyloid 42 ratio correlates with brain structure and fibrillary β-amyloid deposition in cognitively unimpaired individuals at the earliest stages of pre-clinical Alzheimer's disease. Brain Commun . 2025; 7(1): fcae451 (Acceptat).

Agenda